SIRT1 deacetylated and stabilized XRCC1 to promote chemoresistance in lung cancer
暂无分享,去创建一个
Hui-Jye Chen | Hongchuan Jin | Xian Wang | V. Shin | Wenxia Xu | Lifeng Feng | Neelum Aziz Yousafzai | Qiyin Zhou | Qiqi Shi | Jinye Xu
[1] Hua Li,et al. Inhibiting neddylation modification alters mitochondrial morphology and reprograms energy metabolism in cancer cells. , 2019, JCI insight.
[2] K. Nishio,et al. An HER3-targeting antibody–drug conjugate incorporating a DNA topoisomerase I inhibitor U3-1402 conquers EGFR tyrosine kinase inhibitor-resistant NSCLC , 2018, Oncogene.
[3] D. Delia,et al. TSPYL2 is a novel regulator of SIRT1 and p300 activity in response to DNA damage , 2018, Cell Death & Differentiation.
[4] Jianwei Zhou,et al. KDM5B demethylates H3K4 to recruit XRCC1 and promote chemoresistance , 2018, International journal of biological sciences.
[5] Yan Jiao,et al. Sinomenine Induces G1-Phase Cell Cycle Arrest and Apoptosis in Malignant Glioma Cells Via Downregulation of Sirtuin 1 and Induction of p53 Acetylation , 2018, Technology in cancer research & treatment.
[6] H. Inuzuka,et al. SCFβ-TRCP E3 ubiquitin ligase targets the tumor suppressor ZNRF3 for ubiquitination and degradation , 2018, Protein & Cell.
[7] R. Reiter,et al. Melatonin: A pleiotropic molecule that modulates DNA damage response and repair pathways , 2017, Journal of pineal research.
[8] Hongchuan Jin,et al. Tamoxifen activates Nrf2-dependent SQSTM1 transcription to promote endometrial hyperplasia , 2017, Theranostics.
[9] C. Zappa,et al. Non-small cell lung cancer: current treatment and future advances. , 2016, Translational lung cancer research.
[10] P. Potts,et al. An Acetyldegron Triggers CRBN to Take Down the "Q". , 2016, Molecular cell.
[11] Justin M. Reitsma,et al. Glutamine Triggers Acetylation-Dependent Degradation of Glutamine Synthetase via the Thalidomide Receptor Cereblon. , 2016, Molecular cell.
[12] Yingying Zhou,et al. Over-expression of Sirt1 contributes to chemoresistance and indicates poor prognosis in serous epithelial ovarian cancer (EOC) , 2015, Medical Oncology.
[13] T. Shiozawa,et al. Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target , 2015, Laboratory Investigation.
[14] Shukui Wang,et al. JWA reverses cisplatin resistance via the CK2—XRCC1 pathway in human gastric cancer cells , 2014, Cell Death and Disease.
[15] S. Laín,et al. SIRT1 and SIRT2 inhibition impairs pediatric soft tissue sarcoma growth , 2014, Cell Death and Disease.
[16] Raj Kumar,et al. Novel downstream molecular targets of SIRT1 in melanoma: A quantitative proteomics approach , 2014, Oncotarget.
[17] G. Wood,et al. SIRT1 is upregulated in cutaneous T-cell lymphoma, and its inhibition induces growth arrest and apoptosis , 2014, Cell cycle.
[18] J. Stow,et al. Single‐step protease cleavage elution for identification of protein–protein interactions from GST pull‐down and mass spectrometry , 2014, Proteomics.
[19] S. Nakajima,et al. Damage response of XRCC1 at sites of DNA single strand breaks is regulated by phosphorylation and ubiquitylation after degradation of poly(ADP-ribose) , 2013, Journal of Cell Science.
[20] Junchao Cai,et al. miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer. , 2013, Cancer research.
[21] M. Pagano,et al. mTOR generates an auto-amplification loop by triggering the βTrCP- and CK1α-dependent degradation of DEPTOR. , 2011, Molecular cell.
[22] Byoung Kil Lee,et al. Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. , 2011, Human pathology.
[23] Cuk-Seong Kim,et al. SIRT1 deacetylates APE1 and regulates cellular base excision repair , 2009, Nucleic acids research.
[24] Gang Li,et al. JWA regulates XRCC1 and functions as a novel base excision repair protein in oxidative-stress-induced DNA single-strand breaks , 2009, Nucleic acids research.
[25] B. Jung-Hynes,et al. Role of Sirtuin Histone Deacetylase SIRT1 in Prostate Cancer , 2009, Journal of Biological Chemistry.
[26] M. Salto‐Tellez,et al. Function of the SIRT1 protein deacetylase in cancer. , 2007, Biotechnology journal.
[27] Manel Esteller,et al. Epigenetics and aging: the targets and the marks. , 2007, Trends in genetics : TIG.
[28] William Arbuthnot Sir Lane,et al. SIRT1 regulates the function of the Nijmegen breakage syndrome protein. , 2007, Molecular cell.
[29] W. Gu,et al. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage , 2006, Nature Cell Biology.
[30] Brian K. Kennedy,et al. Sirtuins in Aging and Age-Related Disease , 2006, Cell.
[31] Hidde Ploegh,et al. Acetylation of the C terminus of Ku70 by CBP and PCAF controls Bax-mediated apoptosis. , 2004, Molecular cell.
[32] Delin Chen,et al. Mammalian SIRT1 Represses Forkhead Transcription Factors , 2004, Cell.
[33] M. Gottesman,et al. Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.
[34] R. Frye,et al. Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity. , 1999, Biochemical and biophysical research communications.